-
effectivehealthcare-admin.ahrq.gov/products/cervical-ripening/protocol
May 01, 2020 - Prevention
CR
Cervical ripening
EPC
Evidence-based Practice Center
FDA
Federal Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_disposition-comments.pdf
April 28, 2015 - Disposition of Comments for CER 151 Management of Postpartum Hemorrhage
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Management of Postpartum Hemorrhage
Draft review available for public comment from November 21, 2014 to December 17, 2014.
Research Review …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
March 01, 2023 - Disclose support ONLY from entities that could be affected financially by the EPC project, such as drug … Disclose support ONLY from entities that could be affected financially by the EPC project, such as drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
February 05, 2025 - or uncertainty).ti,ab.
27 Delivery of Health Care/ or exp Disease Management/ or "Drug-Related … or "disease
management" or "drug effects" or "inappropriate prescrib*" or "medical error?"
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
December 18, 2019 - Disease Control and Prevention
CR Cervical ripening
EPC Evidence-based Practice Center
FDA Federal Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
October 17, 2012 - Source: www.effectivehealthcare.ahrq.gov
Published Online: October 17, 2012
Evidence-based Practice Center Systematic Review Protocol
Project Title: Meditation Programs for Stress and Well-Being
Amendment Date(s) if applicable: October 10, 2012
(Amendments Details–see Section VII)
I. Background
Me…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cesarean-birth_research.pdf
January 01, 2020 - Donors in Post Term
Pregnancies
Conditions: Prolonged Pregnancy; "Nulliparity"
Interventions: Drug … : IMN; Drug: Placebo
Sponsor: Assistance Publique - Hôpitaux de Paris
Study Design: Allocation: … Obese Non-diabetic Pregnant Women
Conditions: Pregnancy Complications; Obesity
Interventions: Drug … : Metformin; Drug: Placebo
Sponsors: Epsom and St Helier University Hospitals NHS Trust; Fetal … Versus Low Dose Oxytocin for Augmentation of Delayed Labour
Condition: Birth; Delayed
Intervention: Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
February 01, 2012 - While there are fecal occult blood tests that can be purchased
over the counter in drug stores and performed … Food
and Drug Administration (FDA) and has not obtained FDA
clearance or approval. … While there are fecal
occult blood tests that can be purchased over the counter in drug
stores and … Food
and Drug Administration (FDA) and has not obtained FDA
clearance or approval.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
June 15, 2016 - quality of life
IADL Independent Activities of daily Living
NSAID Non-steroidal anti-inflammatory drug … status instrument for measuring clinically
important patient relevant outcomes to
antirheumatic drug … including
discomfort from osteoarthritis
and chronic lower back pain
(http://reference.medscape.co
m/drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
October 01, 2014 - Food and Drug
Administration Medical Devices Registration and Listing),
and individual product Web … The overall rate of adverse drug-related events
was 10%, with all events classified as mild. … Food and Drug Administration approval are ongoing
and this technique is commonly used in other areas
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
September 01, 2020 - suggestion to the medical record, changing the
labeling or signage for clarity, and adding or removing a drug … Intensity of the
Intervention
What is the intensity of the intervention (e.g., dose for drug, duration … patient to intervene, the cost of new equipment, the differential cost of one cleaning solution or one drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-binary-outcomes-evaluation_research.pdf
March 11, 2013 - Only O1 Only
O2
ID#* Description ID#* Description K (N) K (N) K (N)
1 Card CD004587
(1)17
Drug-eluting … Major adverse cardiac
events by 12 months
15 (6325) 6 (1978) 1 (605)
2 Card CD004587
(1)17
Drug-eluting … Drug-eluting stents versus bare metal
stents for angina or acute coronary
syndromes.
-
effectivehealthcare-admin.ahrq.gov/products/methods-balancing-harms-benefits/research-2012
November 01, 2017 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/documentation-burden/protocol
September 01, 2023 - Food and Drug Administration, ClinicalTrials.gov, Health Canada, U.K.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/module_i1.ppt
October 31, 2011 - initial legislation creating the Effective Health Care Program (Section 1013, Medicare Prescription Drug
-
effectivehealthcare-admin.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol
December 01, 2019 - distal protection versus conventional treatment in primary percutaneous coronary intervention: the Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
July 01, 2010 - Food and Drug Administration and
Health Canada.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/presentation.ppt
August 01, 2009 - This table presents baseline and outcomes data only for the randomized controlled trials of one drug,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
July 01, 2010 - distal
protection versus conventional treatment in primary percutaneous coronary
intervention: the Drug
-
effectivehealthcare-admin.ahrq.gov/products/carbohydrate-intake/protocol
May 01, 2024 - as similar to human milk as possible and is established and strictly regulated by the Federal Food, Drug … J Food Drug Anal. 2021 Mar 15;29(1):1-14. doi: 10.38212/2224-6614.3107. PMID: 35696228.